Sava Infond D.O.O. Jazz Pharmaceuticals PLC Transaction History
Sava Infond D.O.O.
- $566 Billion
- Q4 2024
A detailed history of Sava Infond D.O.O. transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Sava Infond D.O.O. holds 3,420 shares of JAZZ stock, worth $463,204. This represents 0.07% of its overall portfolio holdings.
Number of Shares
3,420Holding current value
$463,204% of portfolio
0.07%Shares
1 transactions
Others Institutions Holding JAZZ
# of Institutions
527Shares Held
57.4MCall Options Held
173KPut Options Held
110K-
Black Rock Inc. New York, NY6.15MShares$832 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.04MShares$818 Million0.01% of portfolio
-
Lsv Asset Management Chicago, IL2.49MShares$338 Million0.6% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.21MShares$300 Million0.67% of portfolio
-
State Street Corp Boston, MA1.95MShares$264 Million0.01% of portfolio
About Jazz Pharmaceuticals plc
- Ticker JAZZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,680,700
- Market Cap $8.49B
- Description
- Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...